A 8345

  • New York Assembly Bill
  • 2023 Regular Session
  • Introduced in Assembly
  • Assembly
  • Senate
  • Governor

Directs the department of health to submit a report to the legislature on the feasibility of establishing a drug manufacturing program

Abstract

Directs the department of health to report to the legislature on the feasibility of entering into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs; makes related provisions.

Bill Sponsors (3)

Votes


No votes to display

Actions


May 21, 2024

Assembly

REPORTED REFERRED TO WAYS AND MEANS

May 16, 2024

Assembly

PRINT NUMBER 8345B

Assembly

AMEND (T) AND RECOMMIT TO HEALTH

Jan 18, 2024

Assembly

PRINT NUMBER 8345A

Assembly

AMEND AND RECOMMIT TO HEALTH

Jan 03, 2024

Assembly

REFERRED TO HEALTH

Dec 13, 2023

Assembly

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
A8345 PDF HTML
A8345A PDF
A8345B PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.